Tech Company Financing Transactions
Vivace Therapeutics Funding Round
Canaan Partners and WuXi PharmaTech invested in a $15 million Series A venture round for Vivace Therapeutics. The round closed on 12/31/2015.
Transaction Overview
Canaan Partners (Tim Shannon)
WuXi PharmaTech (Edward Hu)
Company Information
San Mateo, CA 94403
USA
Management Team
Browse more venture capital transactions:
Prev: 12/31/2015: TabbedOut venture capital transaction
Next: 12/31/2015: GroundMetrics venture capital transaction
Share this article
Where The Data Comes From
We do our best to record funding rounds that are announced publicly. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs